Oryzon Genomics Eulerpool naujienos

Oryzon Genomics Eulerpool News

Oryzon Genomics akcijų naujienos

Oryzon Genomics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Oryzon Genomics naujienas mes pateikiame čia.

• liepos 31 d. ·

  Yahoo
  ORYZON reports financial results and corporate update for half-year ending June 30, 2024
• liepos 8 d. ·

  Yahoo
  ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan
• birželio 28 d. ·

  Yahoo
  ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
• birželio 26 d. ·

  Yahoo
  ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
• birželio 14 d. ·

  Yahoo
  ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
• birželio 3 d. ·

  Yahoo
  ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
• gegužės 30 d. ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in June
• gegužės 29 d. ·

  Yahoo
  ORYZON Selected as Associated Partner in the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)
• gegužės 9 d. ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in May
• gegužės 6 d. ·

  Yahoo
  ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024